Corporate news

Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents Grifols conventional antisera reagents recently received licensing approval by the U.S. Food & Drug Administration for manual testing in immunohematology laboratories
+ info

Grifols reaches an agreement with Boya Bio-Pharmaceutical to open plasma collection centers in China Grifols reinforces its long-term strategy to expand and diversify its access to plasma
+ info


Highlights

Manufacturing

Manufacturing
We are a solid company with an international dimension.

Corporate Commitment

People
We contribute to improving people's health and wellbeing by offering safe, high quality products produced using the latest environmentally friendly technology.

When a Dream Comes True. An Illustrated History of 75 Years of Grifols

Read When a Dream Comes True: An illustrated history of 75 years of Grifols to discover the company's roots, and learn more about our history and the development of the company.  + info

 

get to know us better